Passa alla casella di ricercaPassa alla navigazionePassa al contenuto principale

Regulation of mitochondrial morphology and cristae architecture by the TLR4 pathway in human skeletal muscle

  • Mauricio Castro-Sepulveda(corresponding author)
    ,
  • Mauro Tuñón-Suárez
    ,
  • Giovanni Rosales-Soto
    ,
  • Ronald Vargas-Foitzick
    ,
  • Louise Deldicque
    ,
  • Hermann Zbinden-Foncea(corresponding author)
*Corresponding author for this work
Research Output:
Contribution to journal
Article
Peer review

Open Access

Publication Information

Tipo di output

Research Output:
Contribution to journal
Article
Peer review

Lingua originale

English

Numero dell’articolo

1212779

Rivista (volume, numero edizione)

Frontiers in Cell and Developmental Biology (Volume 11)

Attività cardine della pubblicazione

  • Published - 01/01/2023

Stato pubblicazione

Published - 01/01/2023

Publication IDs

  • Scopus: 85164782414

Abstract

In skeletal muscle (SkM), a reduced mitochondrial elongate phenotype is associated with several metabolic disorders like type 2 diabetes mellitus (T2DM). However, the mechanisms contributing to this reduction in mitochondrial elongate phenotype in SkM have not been fully elucidated. It has recently been shown in a SkM cell line that toll-like receptor 4 (TLR4) contributes to the regulation of mitochondrial morphology. However, this has not been investigated in human SkM. Here we found that in human SkM biopsies, TLR4 protein correlated negatively with Opa1 (pro-mitochondrial fusion protein). Moreover, the incubation of human myotubes with LPS reduced mitochondrial size and elongation and induced abnormal mitochondrial cristae, which was prevented with the co-incubation of LPS with TAK242. Finally, T2DM myotubes were found to have reduced mitochondrial elongation and mitochondrial cristae density. Mitochondrial morphology, membrane structure, and insulin-stimulated glucose uptake were restored to healthy levels in T2DM myotubes treated with TAK242. In conclusion, mitochondrial morphology and mitochondrial cristae seem to be regulated by the TLR4 pathway in human SkM. Those mitochondrial alterations might potentially contribute to insulin resistance in the SkM of patients with T2DM.